CAR T cell News and Research

RSS
Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Research could lead to new treatment option for breast cancer patients with brain metastases

Research could lead to new treatment option for breast cancer patients with brain metastases

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

CAR T cells expressing a natural RNA can activate the body’s own T cells against solid tumors

CAR T cells expressing a natural RNA can activate the body’s own T cells against solid tumors

UCLA scientists receive $1 million translational award to advance CAR T cell therapy for rare melanomas

UCLA scientists receive $1 million translational award to advance CAR T cell therapy for rare melanomas

Remote controlling of CAR-T cells with heat to precisely target tumors

Remote controlling of CAR-T cells with heat to precisely target tumors

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Immunotherapy pairs ultrasound with immune cells to destroy tumors without toxic side effects

Immunotherapy pairs ultrasound with immune cells to destroy tumors without toxic side effects

Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Metabolites of intestinal bacteria can positively influence the efficacy of tumor therapies

Metabolites of intestinal bacteria can positively influence the efficacy of tumor therapies

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Three CU researchers recognized for contributions to immunotherapy in childhood cancer

Three CU researchers recognized for contributions to immunotherapy in childhood cancer

New technique can measure metabolic process at the single-cell level

New technique can measure metabolic process at the single-cell level

Different comorbid conditions in COVID-19 patients can impact outcomes of positive PCR test results

Different comorbid conditions in COVID-19 patients can impact outcomes of positive PCR test results

UCSF launches new initiative to propel the development of living therapeutics

UCSF launches new initiative to propel the development of living therapeutics

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

Moffitt Cancer Center presents new data from dozens of clinical research studies at ASCO

Moffitt Cancer Center presents new data from dozens of clinical research studies at ASCO